Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target

SIMPLE SUMMARY: Molecular and histological profiling is crucial for biomarker and therapeutic target discovery, for example, in TNBC. We demonstrated that IL-3Rα expression led to the identification of a subgroup of TNBC patients displaying a poor overall survival. Moreover, we refined TNBC molecula...

Descripción completa

Detalles Bibliográficos
Autores principales: Koni, Malvina, Castellano, Isabella, Venturelli, Emilio, Sarcinella, Alessandro, Lopatina, Tatiana, Grange, Cristina, Cedrino, Massimo, Femminò, Saveria, Cossu-Rocca, Paolo, Orrù, Sandra, D’Ascenzo, Fabrizio, Cotellessa, Ilaria, Tampieri, Cristian, Debernardi, Carla, Cugliari, Giovanni, Matullo, Giuseppe, Camussi, Giovanni, De Miglio, Maria Rosaria, Brizzi, Maria Felice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406043/
https://www.ncbi.nlm.nih.gov/pubmed/36010912
http://dx.doi.org/10.3390/cancers14163918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406043/
https://www.ncbi.nlm.nih.gov/pubmed/36010912
http://dx.doi.org/10.3390/cancers14163918

Ejemplares similares